Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Z. Liu
Observed names:
Ze Liu,
Ze-nan Liu
Institutions:
Shanghai University of Traditional Chinese Medicine,
Shanghai Traditional Chinese Medicine Hospital
Observed institutions:
Shanghai University of Traditional Chinese Medicine,
First Hospital of Jilin University,
Shanghai Traditional Chinese Medicine Hospital,
Peking University Third Hospital
ORCID:
0009-0009-8929-7608
Observed ORCID:
0009-0009-8929-7608
OpenAlex ID:
A5013135020
VP7-2022: An ad-hoc interim overall survival results of niraparib with individualized starting dose as maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer (NORA): A double-blind, randomized, placebo-controlled, phase III trial
2022
·
M.R. Mirza
, X. Wu
, et al.
·
Annals of Oncology
·
10
35O Overall survival of niraparib with individualized starting dose as maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer adjusted for subsequent PARPi use in placebo group: Results from an ad hoc interim analysis for the phase III NORA study
2023
·
X. Wu
, J. Zhu
, et al.
·
ESMO Open
·
1
PDF
Evaluation of the TiaoShenZhiAi Regimen for Patients With Ovarian Cancer Experiencing a Psychoneurological Symptom Cluster: Protocol for a Multicenter, Double-Blind, Randomized Controlled Trial
2026
·
Ze Liu
, Jialiang Yao
, et al.
·
JMIR Research Protocols
Outcome comparison of radical prostatectomy versus seed brachytherapy for clinically localized prostate cancer using two biochemical recurrence definitions
2023
·
Xue-hua Zhu
, Fan Zhang
, et al.
·
BMC Surgery
PDF
Show more works
View as search
Works count:
4
Citation count:
11
H-index:
1
I10-index:
1
Year
Topic
Type